Life Sciences

FDA issues final guidance on submissions of PMA supplements

Device Regulation Alert: Safety, Compliance and Reimbursement News, December 22, 2008

The FDA provided new criteria for medical device manufacturers to determine what type of pre-market application (PMA) to submit for changes involving class III devices.

The new FDA guidance covers proper PMA submission when a manufacturer modifies a device’s:

  • Design or labeling
  • Manufacturing process
  • Location of manufacturing, processing, or packaging

The guidance also applies to modifications made as a result of a recall or field corrective action.

It also provides examples of various types of device modifications, explains what type of testing was performed to support the safety and effectiveness of each device modification, and describes the type of PMA that was submitted.

Comments

0 comments on “FDA issues final guidance on submissions of PMA supplements

 

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Complete Guide to Lab Safety, 3rd Ed.

    The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...

Most Popular